98%
921
2 minutes
20
We investigated the behavior of renal cells cultivated in microfluidic biochips when exposed to 50 μM of ifosfamide, an antineoplastic drug treatment. The microarray analysis revealed that ifosfamide had any effect in Petri conditions. The microfluidic biochips induced an early inflammatory response in the MDCK in the untreated cells. This was attributed to cells adapting to the dynamics and micro environment created by the biochips. This led to modulations in the mitochondria dysfunction pathway, the Nrf-2 and oxidative stress pathways and some related cancer genes. When exposed to 50 μM of ifosfamide, we detected a modulation of the pathways related to the cancer and inflammation in the MDCK cultivated in the biochips via modulation of the ATM, p53, MAP Kinase, Nrf-2 and NFKB signaling. In addition, the genes identified and related proteins affected by the ifosfamide treatment in the biochips such as TXNRD1, HSP40 (DNAJB4 and DNAJB9), HSP70 (HSPA9), p21 (CDKN1A), TP53, IKBalpha (NFKBIA) are reported to be the molecular targets in cancer therapy. We also found that the integrin pathway was perturbed with the ifosfamide treatment. Finally, the MYC proto-oncogene appeared to be a potential bridge between the integrin signaling and the anti-inflammatory response.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ygeno.2012.05.001 | DOI Listing |
Biosensors (Basel)
August 2025
College of Information Science and Engineering, Ritsumeikan University, Suita 567-8570, Japan.
Micro Electrode Dot Array (MEDA) biochips have recently attracted considerable attention in the biochemical and medical industries. MEDA biochips manipulate micro droplets for biochemical experiments such as DNA analysis. Droplets on MEDA biochips are moved using the Electrowetting on Dielectric (EWOD) effect, but a portion of a droplet may remain on a cell after passing through, contaminating the cell.
View Article and Find Full Text PDFBiosensors (Basel)
August 2025
College of Information Science and Engineering, Ritsumeikan University, Osaka 567-8570, Japan.
In recent years, digital microfluidic biochips (DMFBs), based on microfluidic technology, have attracted attention as compact and flexible experimental devices. DMFBs are widely applied in biochemistry and medical fields, including point-of-care clinical diagnostics and PCR testing. Among them, micro electrode dot array (MEDA) biochips, composed of numerous microelectrodes, have overcome the limitations of conventional chips by enabling finer droplet manipulation and real-time sensing, thus significantly improving experimental efficiency.
View Article and Find Full Text PDFAdv Sci (Weinh)
August 2025
Department of Mechanical Engineering, The University of Hong Kong, Pokfulam Road, Hong Kong SAR, 000000, China.
The anticipated rise in the prevalence of Alzheimer's disease (AD) under global demographic shifts necessitates the development of universally accessible screening and diagnostic tools, of which blood tests hold the promise. However, the widespread adoption of blood tests remains impeded by the lack of analytically validated biomarkers and accessible decentralized platforms. Here, the study presents a portable and automated micro-immunobeads-based electromagnetic operation system, termed MEMOs, targeting potential AD blood biomarker exosome-bound Aβ42 (Exo-Aβ42), for automated blood testing of AD.
View Article and Find Full Text PDFAnal Chem
August 2025
School of Environmental Science and Technology, Key Laboratory of Industrial Ecology and Environmental Engineering (Ministry of Education), Dalian POCT Laboratory, Dalian University of Technology, Dalian 116024, China.
Conventional bacterial detection relies on culture-based methods and nucleic acid amplification. These multistep procedures increase complexity, processing time, and cost, limiting their utility in point-of-care (POC) diagnostics. To address this, we developed fluorogenic DNAzymes (FDz) for rapid bacterial detection on a photonic-crystal-assisted microfluidic biochip (PC-μchip).
View Article and Find Full Text PDFMicromachines (Basel)
June 2025
Institute of Nanoscience and Nanotechnology, NCSR "Demokritos", Patriarchou Gregoriou E' and 27 Neapoleos Str., 15341 Aghia Paraskevi, Greece.
OoC systems employing human cells mirror the functionality of human organs and faithfully simulate their physiological microfluidic environment. Despite the potential of OoC technology in emulating tissue complexity, a significant gap persists in the continuous real-time monitoring of cellular behaviors and their responses to external stimuli, arising from the lack of biosensors integrated onto OoC microfluidic platforms. Addressing this limitation constitutes the primary objective of this study.
View Article and Find Full Text PDF